3-Cyanobenzylchloride | CAS:64407-07-4

We serve 3-Cyanobenzylchloride CAS:64407-07-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Cyanobenzylchloride

CAS No: 64407-07-4
Product Name: 3-Cyanobenzylchloride
Other Name:
3-Cyanobenzylchloride
3-(Chloromethyl)benzonitrile
3-Cyano benzyl chloride
 
Density: 1.2±0.1 g/cm3
Boiling Point: 259.0±15.0 °C at 760 mmHg
Molecular Formula: C8H6ClN
Molecular Weight: 151.593
Flash Point: 111.4±15.4 °C
Exact Mass: 151.018875
PSA: 23.79000
LogP: 1.92
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.551
 
Specification
Appearance: White crystalline powder
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, organic synthesis intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Cyanobenzylchloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Cyano benzyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(Chloromethyl)benzonitrile Use and application,3-(Chloromethyl)benzonitrile technical grade,usp/ep/jp grade.


Related News: Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.1-Benzylpiperazine dihydrochloride manufacturer Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl] acetate,hydrochloride supplier The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.Difurfurylsulfide vendor Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.